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We examined the distribution of selected raft proteins on the sarcolemma of skeletal myoﬁbers and the role of cholesterol
environment in the distribution. Immunoﬂuorescence staining showed that ﬂotillin-1 and inﬂuenza hemagglutinin exhibited rafts
that located in the domains deﬁcient of the dystrophin glycoprotein complex, but the distribution patterns of the two proteins
were diﬀerent. Cholesterol depletion from the sarcolemma by means of methyl-β-cyclodextrin resulted in distorted caveolar
morphology and redistribution of the caveolin 3 protein. Concomitantly, the water permeability of the sarcolemma increased
signiﬁcantly. However, cholesterol depletion did not reshuﬄe ﬂotillin 1 or hemagglutinin. Furthermore, a hemagglutinin variant
that lacked a raft-targeting signals exhibited a similar distribution pattern as the native raft protein. These ﬁndings indicate that
eachraftproteinexhibitsastrictlydeﬁneddistributioninthesarcolemma.Onlythedistributionofcaveolin3thatbindscholesterol
was exclusively dependent on cholesterol environment.
1.Introduction
Skeletal myoﬁbers are unique cells that have a large plasma
membrane separated into sarcolemma and transverse tu-
bules. The dystrophin glycoprotein complex (DGC) dis-
tributes at the sarcolemma in an organized fashion forming
a cross-striated pattern over the I-bands and M-lines of the
underlying myoﬁbrils and longitudinal stripes over the I-
A junctional areas [1, 2]. DGC is thought to stabilize the
sarcolemmal membrane that is subject to mechanical stress
during muscle contractions. Accordingly, inherited defects
in the components of the DGC and especially in dystrophin
are manifested in various types of dystrophia diseases [3].
Interestingly, many endogenous sarcolemmal proteins such
as Na,K-ATPase [2], transferrin receptor [4], caveolin 3
(cav 3) [4], chloride channel ClC-1 [5], and aquaporin 4
[6] occupy the areas covered by the DGC. Caveolae pit
structures that contain cav 3 protein also locate to the
DGC regions. Several viral model glycoproteins also show a
speciﬁc localization pattern in relation to the DGC mosaic
[4].
Studies with mononucleated cells and giant plasma
membrane vesicles have revealed that caveolins and several
lipid-anchored proteins show a strong preference to choles-
terol and sphingolipid-enriched lipid islets called rafts [7,
8]. These microdomains have been reported to exist as
dispersed units of nanometer scale, but they may also
form large clusters of several micrometers in size that lack
nonraft proteins [9–12]. The integrity of rafts is crucially
dependent on cholesterol. Accordingly, cholesterol depletion
by a cholesterol-sequestering drug, methyl-β-cyclodextrin
(CDX), inhibits patching of antibody cross-linked raft
proteins and increases the diﬀusion rates of certain raft-
associated proteins [10, 13, 14].
Since the sarcolemma of myoﬁbers comprises a regu-
larly repeated two-domain mosaic and sarcolemmal nonraft
proteins have been shown to comply with this pattern, we
examined here whether the distribution patterns of raft
proteins were domain speciﬁc. We found that contrasting
the behavior of cav 3, ﬂotillin 1, and the classical raft
marker inﬂuenza virus hemagglutinin (HA) localized into
the domains deﬁcient of DGC. We next investigated whether2 Biochemistry Research International
the cholesterol environment aﬀected the distribution of raft
proteins between the sarcolemmal domains. Interestingly,
the localization pattern of the caveolar protein cav 3 was
altereduponcholesteroldepletion,andthecaveolarpitswere
deformedordestroyed.However,depletionofcholesteroldid
not reshuﬄe ﬂotillin 1 or HA. Furthermore, removal of the
raft-targeting signals from HA indicated that the domain-
speciﬁc localization was not dependent on the raft-targeting
signals. While cholesterol was important to locate cav 3 into
caveolae, it did not aﬀect the distribution of ﬂotillin 1 or HA
on the sarcolemma.
2. Methods
2.1. Isolation and Cultivation of Myoﬁbers. Myoﬁbers were
isolated from the ﬂexor digitorum brevis (FDB) muscle of
three-month-old female rats by using collagenase digestion
as described [15]. The isolated myoﬁbers were mounted on
cell culture dishes coated with Matrigel (Becton-Dickinson
Biosciences, Franklin Lake, NJ, USA) and cultivated in mini-
mal essential medium (MEM) supplemented with 5% horse
serum, L-glutamine and penicillin-streptomycin. For mea-
surements of live cells, the isolated myoﬁbers were mounted
on Matrigel-coated glass-bottom dishes (WillcoWells, Ams-
terdam, Netherlands).
2.2. CDX Treatments. Treatments with CDX (Sigma-
Aldrich, St. Louis, Mo. USA) were performed in MEM
containing L-glutamine, penicillin-streptomycin, and 0.05%
(v/v)heat-inactivatedandlipoprotein-depleted horseserum.
The serum was delipidiﬁed by sequential ultracentrifugation
prior to use to remove lipoprotein components, as described
by Goldstein et al. [16]. Prior to the CDX treatments, the
myoﬁber cultures were washed two times with MEM. The
ﬁbers were incubated in the presence of appropriate CDX
concentrations in a volume of 0.5mL for 1h at 37◦C.
2.3. Detergent Extractions. Isolated myoﬁbers were scraped
from the culture dishes and pelleted by centrifugation at
200g for 2min in a table top centrifuge. After that, the
myoﬁber pellets were suspended in cold phosphate buﬀered
saline (PBS) containing 1% Triton X-100 and complete
protease inhibitor cocktail (Roche, Basel, Switzerland) and
incubated for 10min in an ice bath. The detergent-insoluble
proteins were pelleted by centrifugation at 75,000g for 2.5h
at 4◦C. Proteins in the supernatants were precipitated with
10% TCA. Proteins in the pellets and the supernatants
were separated with SDS/PAGE followed by western blotting
using rabbit antiﬂotillin 1 (Sigma-Aldrich) as primary anti-
body and peroxidase-conjugated anti-rabbit IgG (Bio-Rad
Laboratories) as secondary antibodies. Detection was with
chemiluminescence detection reagent (GE Healthcare) using
Hyperﬁlm (GE Healthcare).
2.4. Hypotonic Swelling Experiments. Freshly isolated myo-
ﬁbers on glass-bottom dishes were either treated or not
treated with CDX and then incubated in the presence of
10mM ﬂuorophore Calcein-AM (Invitrogen, Eugene, OR,
USA) for 5min at 37◦C. Thereafter, the culture was washed
two times with MEM and covered with an additional layer
of Matrigel to prevent detachment of myoﬁbers during sub-
sequent treatments as described in [6]. The myoﬁbers were
examined with Zeiss LSM510 confocal microscope (Carl
Zeiss, G¨ ottingen, Germany), and those showing a homoge-
nousﬂuorescencewerechosenformeasurements.Theregion
of interest was the entire myoﬁber, and the focal plane was
set at the core region. A 60s recording was performed before
the hypotonic shock that was induced by changing isotonic
PBS (300mosM) to hypotonic (150mosM). Changing the
medium resulted in a variable amount of movement of the
myoﬁber being measured. Therefore, the region of interest
wasmanuallyrepositionedtocorrespondtothenewlocation
of the myoﬁber. All the recordings were performed at
23 ± 1◦C by measuring the mean ﬂuorescence intensity
at 2 s intervals. The ﬂuorescence intensity changes were
analyzed by using Zeiss LSM510 Pascal software, and the
measurement covered the entire ﬁber. Since a small fraction
of the FDB myoﬁbers contains aquaporin 4 [6], the presence
of aquaporin 4 was determined by immunoﬂuorescence
staining after the recordings. Measurements from myoﬁbers
containing aquaporin 4 were rejected since aquaporin 4 is a
water channel.
2.5. Electron Microscopy. For immunolocalization studies,
extensor digitorum longus (EDL) muscle was dissected and
ﬁxed with 4% paraformaldehyde in 0.1M phosphate buﬀer
for 1h, sliced in small pieces and placed in 2.3M sucrose
overnight. Alternatively, isolated FDB myoﬁbers were ﬁxed
with 4% paraformaldehyde for 1h in 0.1M phosphate buﬀer
containing 73mM sucrose, and then detached from the
culture dishes and centrifuged at 2000g for 1min. After
washingswithPBS,thepelletsweresuspendedin12%gelatin
at 37◦C, centrifuged at 3000g for 5min, and chilled in an ice
bath for 30min. The congealed gelatin was sliced in small
pieces and placed in 2.3M sucrose overnight. The pieces of
EDL or the gelatin-embedded FDB myoﬁbers were frozen
with liquid nitrogen, and thin sections (200nm) were cut.
The sections were ﬁrst incubated in 50mM glycine in PBS
and then in 5% bovine serum albumin (BSA) supplemented
with 0.1% cold water ﬁsh skin gelatin (Aurion, Wageningen,
Netherlands) in PBS to block nonspeciﬁc binding. Antibod-
ies were diluted with 0.1% BSA-C (Aurion) in PBS, and
the incubations were for 1h at 37◦C. Rabbit antimouse
secondary antibodies (Zymed Laboratories) and protein
A-gold complex [17] were used for detection. Sections
were examined with Philips CM100 transmission electron
microscope.
For conventional transmission electron microscopy, the
isolated myoﬁbers were ﬁxed with 1.5% glutaraldehyde in
PBS.Theﬁxedﬁberswerescrapedandpelletedbycentrifuga-
tion and immersed in 12% agarose. Osmium tetroxide (1%)
was used for postﬁxation, and the myoﬁbers were embed-
ded in Epon LX 112 (Ladd Research Industries, Burling-
ton, Vt. USA). Thin sections (150nm) were examined
with the Philips CM100 electron microscope. The number
of caveolae/μm of the sarcolemma was calculated using 4–
7 photographed ﬁelds/ﬁber. Image analysis was performed
with UTHSCSA Image Tool for Windows version 3.Biochemistry Research International 3
2.6. Recombinant Viruses and In Vitro Mutagenesis. Prepa-
ration of recombinant Semliki Forest Virus (SFV) particles
encoding HA Japan/A/305/57 [Genbank: DQ508841.1] has
been described previously [18]. To generate SFV particles
encoding a mutant HA lacking all known raft-targeting sig-
nals, we used the mutant 2A511 HA described by Scheiﬀele
et al. [19]. The cDNA of the mutant 2A511 HA in pSFV
vector was subjected to in vitro mutagenesis to change the
triplets encoding cysteine 536 at the C-terminal end of the
transmembrane domain and cysteines 543 and 546 in the
C-terminal tail into triplets encoding serines, to prevent
palmitoylation of the protein [7]. The in vitro mutagenesis
was performed by using the QuickChange site directed in
vitro mutagenesis kit (Stratagene, La Jolla, CA, USA). That
the mutated product had the desired sequence was veriﬁed
with ABI PRISM 3130XL sequencer and BigDye Terminator
v1.1 Cycle Sequencing Kit (Applied Biosystems Inc., Foster
City, CA, USA).
The isolated myoﬁbers were infected with the recSFVs by
applying viral stock medium into the culture medium at 1:3
dilution. The infection was allowed to proceed for 16–24h at
37◦C.
2.7. Immunohistochemistry. Isolated myoﬁbers were ﬁxed
with 3% paraformaldehyde in PBS for 10min. After perme-
abilization with 1% Triton X-100, the nonspeciﬁc binding
was blocked with 1% BSA for 10min. Primary antibodies
were applied for 30min at 37◦Co r2ha tr o o mt e m p e r a t u r e .
The primary antibodies used were rabbit antiﬂotillin 1
(Sigma-Aldrich), mouse anti-β-dystroglycan (Novocastra
Laboratories Ltd, Benton Lane, UK), mouse anti-cav 3
(Becton Dickinson, Franklin Lakes, NJ, USA), and mouse
antidihydropyridine receptor (DHPR) (Aﬃnity Bioreagents
Inc., Golden, CO, USA). Secondary antibodies were Alexa
488-conjugated anti-rabbit IgG (Invitrogen) or Alexa 568-
conjugated anti-mouse IgG (Invitrogen), and incubations
lasted for 30min at 37◦C. HA on the sarcolemma was
detected by adding rabbit anti-HA antiserum [19] into the
culture medium at 1:100 dilution. Incubation was for 1.5h
at 10–12◦Cf o l l o w e db yt w ow a s h e sw i t hP B Sa n dﬁ x a t i o n
withparaformaldehyde.ThentheAlexa488-conjugatedanti-
rabbitIgGwasappliedandincubatedfor30minat37◦C.The
myoﬁbers were next permeabilized by a 5-minute treatment
with 1% Triton X-100 in PBS and processed for double
immunoﬂuorescence staining for β-dystroglycan. Negative
controls for all antibodies were performed by omitting
the primary antibody, and these were blank. Samples were
examined with Zeiss LSM510 confocal microscope.
2.8. Statistics. All the data are expressed as mean ± SD, and
n indicates the number of determinations. Two-sample t-test
was used to compare two groups, and one-tailed hypothesis
testing was used to determine P values. P<0.05 was
considered statistically signiﬁcant.
3. Results
3.1. Flotillin 1 and Cav 3 Reside in Separate Membrane Mi-
crodomains. The ﬂotillin rafts are distinct from caveolae
in mononucleated cells [20] in which the ﬂotillin micro-
domains can exist in either ﬂat or invaginated state [21].
Here, we examined whether ﬂotillin 1 microdomains in
skeletal muscle cells were distinct from the caveolae that
contain cav 3. For this purpose, we performed double imm-
unoﬂuorescence staining for the two proteins in isolated
myoﬁbers that provide a view over the muscle cell surface.
Figures 1(a)–1(c) show that ﬂotillin 1 appeared as clusters at
the A-band regions in the domains deﬁcient of DGC. These
domains are lacking cav 3 [4].
Since we found ﬂotillin 1 in the regions deﬁcient of
DGC that are known to harbor transverse tubule openings
[4], we next performed double staining for ﬂotillin 1 and
the transverse tubule marker DHPR. Confocal sectioning
indicated that ﬂotillin 1 staining ﬂanked that of the DHPR
staining (Figures 1(d)–1(f)), suggesting that the two proteins
were close to each other but did not overlap. A longitudinal
confocal section through a myoﬁber (Figures 1(g)–1(i))
suggests that ﬂotillin 1 marked structures in the transverse
tubule neck portions. Supporting this, immunoelectron
microscopy studies consistently indicated that ﬂotillin 1
located in structures 50–100nm beneath the sarcolemmal
membrane. Figure 1(j) shows an example.
3.2. Cholesterol Depletion Partially Reshuﬄes Cav 3 and
Deforms Caveolae but Does Not Aﬀect Flotillin 1 Distribution.
We have previously reported that cav 3 disappears from
the sarcolemma upon cholesterol depletion [6]. The ﬁnding
that ﬂotillin and cav 3 seem to reside in discrete structures
prompted us to investigate whether depletion of cholesterol
aﬀected the distribution pattern of ﬂotillin 1, too. We found
that the immunoﬂuorescence staining pattern of ﬂotillin 1
remained unchanged after CDX treatment of the isolated
myoﬁbers. The intensity of ﬂotillin immunostaining varied
considerably from ﬁber to ﬁber; however, a systematic inten-
sity change could not be observed upon CDX treatment. The
intensityofthecav3stainingonthesarcolemmawasreduced
in variable extent. A salient feature after the CDX treatment
was that rows of spots of cav 3 staining appeared beneath the
sarcolemma (Figure 2(e)). The staining pattern mimicked
that of DHPR suggesting localization of cav 3 in transverse
tubules. Immunogold labeling veriﬁed that after cholesterol
depletion cav 3 was abundant especially at the neck portions
of the transverse tubules. Figures 2(h)–2(i) summarize these
results.
We next subjected cultured myoﬁbers to various con-
centrations of CDX followed by extraction with cold Triton
X-100. We found that ﬂotillin 1 was sparingly soluble in
Triton X-100 (soluble fraction was 21.5 ± 3.7%, n = 2),
and surprisingly, CDX treatment only slightly increased its
detergent solubility (3mM CDX: 30.4 ± 5.6%, n = 3; 5mM
CDX: 31±6.4%, n = 3). Similar analysis was also performed
for cav 3, indicating that CDX treatment did not increase
the solubility of the protein in Triton X-100. Figure 3 shows
an example of the results. Both ﬂotillin 1 as well as cav 3
ﬂoated in sucrose gradients, indicating that the insolubility
was due to association with rafts. These ﬁndings suggest that
ﬂotillin 1, like cav 3, resides in a very compactly packed lipid
environment.4 Biochemistry Research International
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
(j)
Figure 1:Flotillin1residesintheDGC-deﬁcientregionsinstructuresneartransversetubuleopenings.Aconfocalsectionatthesarcolemma
level indicates that ﬂotillin 1 (a) appears as spots of irregular shape. Double staining for β- d y s t r o g l y c a n( b )a n dt h em e r g e di m a g e( c )s h o w
that dystroglycan and ﬂotillin 1 do not colocalize. A confocal section at the sarcolemma level indicated that ﬂotillin 1 (d) and DHPR (e) that
mark transverse tubules are ﬂanking each other, demonstrated in the merged image (f). A longitudinal confocal section in the middle of a
myoﬁber indicates that ﬂotillin 1 (g) exhibits intense staining that seems to be an extension of the DHPR staining (h) as demonstrated in
the merged image (i). Immunoelectron microscopy for ﬂotillin 1 in EDL section shows gold particles (arrowhead) in a structure beneath the
sarcolemma near the transverse tubule neck (arrow) (j). Scale bars, 2μm (a–i); 250nm (j).Biochemistry Research International 5
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 2: Cav 3 and ﬂotillin 1 reside in diﬀerent types of rafts. Cav 3 (red) normally exhibits a cross-striated distribution pattern over the
I bands, while ﬂotillin 1 (green) locates to the A-band regions lacking cav 3 (a). A confocal section 5μm beneath the sarcolemma shows
neither ﬂotillin 1 nor cav 3 (b). A confocal section at the middle of the myoﬁber shows ﬂotillin and cav 3 on the sarcolemma exclusively (c).
After treatment with 5mM CDX, the sarcolemmal staining patterns retain (d), however, a confocal section 5μm beneath the sarcolemma of
the CDX-treated myoﬁber reveals double rows of dots of cav 3 (e). Some subsarcolemmal dots are also visible in the middle section (f). Scale
bars, 2μm. The ﬂotillin and cav 3 staining patterns were abolished upon omitting the primary antibodies (g). EM immunogold labeling of
FDB cryosections shows particles indicating the presence of cav 3 predominantly in the sarcolemma in myoﬁbers not treated with CDX (h).
In FDB myoﬁber treated with 5mM CDX, the immunogold particles are associated with the transverse tubules, marked by dotted lines (i).
Scale bar in (h, i) 250nm.
Since cav 3 disappears from the sarcolemma upon CDX
treatment, we next examined whether caveolae pits disap-
peared. Transmission electron microscopy studies of myo-
ﬁbers after CDX treatment indicated that, in comparison to
the normal morphology of caveolae (Figure 4(a)), deforma-
tion occurred at 1mM concentration of the drug (Figure
4(b)). Furthermore, the number of caveolae was reduced by
about50%inCDX-treatedmyoﬁbers(2.9±0.34caveola/μm,
n = 5 photographs) as compared to the controls without any
drug treatment (5.9 ± 0.01caveola/μm, n = 2). Increasing
the CDX concentration to 5mM resulted in destruction
of the caveolar morphology (Figure 4(c)). These ﬁndings6 Biochemistry Research International
No detergent TX-100
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5 mM 
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Flot1
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Figure 3: Flotillin 1 is more sparingly soluble in cold Triton X-100
than cav 3. Isolated myoﬁbers were treated with 0, 3, and 5mM
CDXandthenextractedwith1%TritonX-100.Solublematerial(S)
and pellets (Ps) were subjected to SDS/PAGE and western blotting
using speciﬁc antibodies. Treatment of the myoﬁbers with CDX
only slightly increased the solubility of ﬂotillin 1 to the detergent,
whereas the solubility of cav 3 remained unaﬀected.
are compatible with those obtained with nonmuscle cells
[22].
In addition to the morphology of caveolae, cholesterol
has an impact on the water permeability of membranes
[23]. This question is especially important with regard to
the sarcolemma, owing to the fact that cholesterol-lowering
medication has adverse eﬀects on skeletal muscle. We
therefore investigated whether the cholesterol depletion
altered the swelling response of myoﬁbers under hypotonic
conditions. Interestingly, we found that after switching from
isotonic to hypotonic osmolarity the intensity of calcein-
AM reduced signiﬁcantly more in the cholesterol-depleted
myoﬁbers as compared to control myoﬁbers (Figure 5).
This suggests that the sarcolemma became more permeable
to water. The eﬀect was repeatable with 2mM CDX, but
at higher drug concentrations, a major fraction of the
myoﬁbers became leaky for the ﬂuorophore as indicated
by a slight decrease of the ﬂuorescence intensity during
the prerecording period before the hypotonic shock. The
myoﬁbers which remained intact after treatment with 3mM
CDX, however, did not show any additional increase in water
permeability as compared with the myoﬁbers treated with
2mM drug concentration.
3.3. The Existence and Localization of Inﬂuenza HA Micro-
domains Are Not Dependent on the Association with Rafts.
The inﬂuenza HA is a viral model glycoprotein that was
shown to acquire insolubility in detergents upon travelling
from the Golgi apparatus to the plasma membrane [24].
Recent superresolution microscopy observations show that
HA at the plasma membrane associates with microdomains
ranging from 40nm to irregularly shaped clusters of up to
several microns [12]. Here, we utilized the inﬂuenza HA and
its variants that are excluded from rafts, in order to further
analyze whether raft association played a role in protein
targeting to the sarcolemmal domains. We ﬁrst expressed the
raft-associated native HA in isolated myoﬁbers and analyzed
its localization on the sarcolemma in relation to the DGC.
In order to avoid interference caused by inﬂuenza virions
that bind to the sarcolemma and the interactions of the HA
with other viral proteins, we expressed HA by using recSFV
instead of the parent inﬂuenza virus. We found that during
the propagation of the infection, the HA protein appeared as
small dots of uniform size. Some dots located in the domains
devoid of DGC, but the majority located to the domain
borderlines thus ﬂanking the DGC domains (Figure 6(a)).
Accordingly, this localization pattern is clearly distinct from
that of caveolae, and it also seems diﬀerent from that of
ﬂotillin 1 that exhibited clusters of irregular shapes and had
a tendency to mark the central areas of the domains lacking
DGC.
Since the anti-HA antibodies were applied to live myo-
ﬁbers, it is possible that the dots seen were induced
by antibody cross-linking. To exclude this possibility, we
performed ﬁxing with paraformaldehyde followed by imm-
unoﬂuorescence staining without permeabilization. Fixation
prior to the application of antibodies slightly permeabilized
the sarcolemmaand caused some background staining; how-
ever, dots of HA similar to those seen when antibodies were
applied before ﬁxation were observed (Figure 6(g)), locating
totheDGC-deﬁcientareasbutﬂankingtheDGCareas.Upon
further propagation of the infection there appeared HA dots
also within the domain occupied by the DGC (Figure 6(d)).
This was only seen in myoﬁbers exhibiting very intense
ﬂuorescence, suggesting overexpression conditions.
In order to approach the question whether it was the
association with rafts that determined the localization of
HA, we ﬁrst treated the myoﬁbers with CDX to deplete
cholesterol. This treatment had no eﬀect on the distribution
of the protein (Figure 6(e)). Next we expressed the variant
HA (2A511) that lacked the raft-targeting signals, namely
speciﬁc hydrophobic amino acids in the transmembrane
domain [19]. This mutant has been shown to be detergent
s o l u b l ei nm y o t u b e s[ 18]. As the wild-type HA, the variant
HA was expressed using recSFV, and it was found to
appear as dots and to localize to the domain borderlines.
Finally, we expressed the 2A511 mutant that also lacked
palmitoylation sites [7] and found it to behave like the native
HA (Figure 6(f)). We did not observe any diﬀerence in the
dot size between the raft-associated and nonraft-associated
forms of HA. Taken together, these ﬁndings imply that lipid
environment had no crucial role in the targeting of HA.
4. Discussion
Previous studies have indicated that several sarcolemmal
proteins reside within the DGC domains of the sarcolemmal
mosaic [2, 4–6]. Here, we analyzed the distribution pattern
of proteins which are associated with sphingolipid- and
cholesterol-based microdomains, called rafts, and whether
the raft association dictated their distribution patterns.
When investigating the localization of three selected raft
proteins on the sarcolemma, we found three diﬀerent types
of organization patterns which were dependent on the
organization of the DGC. The caveolae rafts harboring cav
3 resided within the DGC domains, and their integrity was
strictly dependent on cholesterol. There were clusters of raft
proteins, namely ﬂotillin 1 and HA also in the domains
lacking DGC. In this respect, the situation resembles that in
the polarized epithelial cells in which there are rafts both in
theapicalaswellasthebasolateraldomains[25–27].Itseems
that the integrities of the ﬂotillin and HA protein clustersBiochemistry Research International 7
(a) (b) (c)
Figure 4: Cholesterol depletion destroys the morphology of caveolae. (a) In an intact FDB myoﬁber, there are abundantly ﬂask-shaped
caveolae that form rosettes (marked by arrowheads) beneath the sarcolemma. (b) Treatment with 1mM CDX reduces the number of
caveolae, and the morphology of individual caveolae (arrowheads) is distorted. (c) Treatment with 5mM CDX results in ﬂattened caveolae
without any distinguishable morphology. Scale bar, 500nm.
werenotdependentontheassociationwithalipid-basedraft
platform.
The omega-shaped invaginations called caveolae com-
prise a special type of rafts. In skeletal myoﬁbers, these
caveolae are located at the sarcolemma and colocalize with
the DGC at I-band regions [4]. That the caveolae structures
and the localization of cav 3 were dependent on cholesterol is
explained by the fact that cav 3 is a cholesterol-binding pro-
tein. Abolishing this interaction results in increased mobility
of the protein, and it was shifted into the transverse tubules.
Previous studies have localized small amounts of cav 3 in the
transverse tubules [28]; however, the antibodies we used did
not recognize this component. We presume that relatively
large amounts of cav 3 shifted to the transverse tubules upon
cholesterol depletion whereby it became recognizable to the
present antibodies. The fact that cholesterol depletion did
not totally redistribute cav 3 is compatible with the idea that
this protein is partially bound to DGC via β-dystroglycan
[29]. A curved membrane may bring cav 3 in the vicinity of
the membrane surrounding the caveolae, allowing the two
proteins to interact in this restricted area. It is also important
to note that the cholesterol depletion did not change the
distribution pattern of β-dystroglycan although this protein
has been previously suggested to reside in rafts [30].
A recent study has posed that the cav 3 protein residing
in caveolae also localizes to the DGC-deﬁcient areas at the
necks of the transverse tubules[31].Our resultsareatvariety
with this ﬁnding since cav 3 appeared to accumulate into
transverse tubule necks upon cholesterol depletion only.
Instead, we found that ﬂotillin 1 that structurally resembles
caveolins was exclusively located in the DGC-deﬁcient
membrane domains. Interestingly, there are caveolae-like
ﬂasks attached to the necks of the transverse tubules
protruding to the sarcolemma [4], and our results suggest
that ﬂotillin 1 is present in those structures. Accordingly,
electron microscopic immunogold labeling experiments
(Figure 1(j)), although suﬀering from low labeling intensity,
support the idea of ﬂotillin 1 locating to the ﬂask structures
at the transverse tubule openings. In mononucleated cells,
ﬂotillin 1 forms ﬂask structures together with ﬂotillin 2
[21]. Flotillin 2 is not expressed in skeletal muscle cells
[32]; however, there may still be an unknown partner for
ﬂotillin 1 to form ﬂask structures. It is notable that the
glycophosphatidylinositol-anchored carbonic anhydrase IV
wasrecentlylocalizedtotransversetubuleopeningsinmouse
skeletalmyoﬁbers[33],anditispossiblethatthisproteinand
ﬂotillin 1 reside in the same lipid rafts.
We found that the distribution patterns of ﬂotillin 1
and HA did not change upon cholesterol removal. This is
interesting since the organization of rafts and the spatial
distribution of some raft-associated proteins are crucially
dependent on cholesterol in mononucleated cells. Accord-
ingly, removal of cholesterol has been shown to increase
the mobility of raft-associated membrane proteins and
to disrupt the organization of microdomains harboring
proteins anchored by glycophosphatidyl inositol, resulting in
intermixing of diﬀerent types of rafts [13, 14, 34, 35]. It is
notable that cholesterol depletion did not markedly render
ﬂotillin 1 soluble in Triton X-100, suggesting an especially
rigid lipid organization such as suggested by Ilangumaran
and Hoessli [36]. Alternatively, ﬂotillin-1 was bound to
subsarcolemmal structures which retain the microdomains
in position even upon cholesterol depletion. Our results
show that, in addition to the changes in the morphology
of caveolae, the barrier function of the plasma membrane is
altered as manifested by increased water permeability when
cholesterol level is lowered.
Segregation of proteins in liquid-ordered microdomains
takes place by means of several known raft-targeting signals
[7, 8, 19]. It is possible that removal of these signals leads
to diverse distribution patterns of raft-associated proteins on
the cell surface. Indeed, it has been demonstrated that raft
proteins are transported to the plasma membrane in speciﬁc
transport vesicles in epithelial cells and also in yeast [37, 38].
We used the prototype raft protein inﬂuenza HA and found
that HA appeared as small dots, the size of which apparently8 Biochemistry Research International
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Figure 5: Cholesterol depletion increases the water permeability of isolated myoﬁbers. (a) Fluorescence micrographs of a calcein-loaded
myoﬁber before (left) and 140s after switching to the hypotonic buﬀer (right) that indicates decreased ﬂuorescence. The myoﬁber was not
treated with CDX. Scale bar, 50μm. (b) Examples of the relative ﬂuorescence (ﬂuorescence at certain time point divided by the ﬂuorescence
at the beginning of the experiment) recordings for myoﬁbers treated or not treated with CDX are shown. A sharp decline of the ﬂuorescence
intensity was often seen upon switching to the hypotonic buﬀer, owing to sample movement. (c) The change of ﬂuorescence intensity is
presented as a percentage between the value of ﬂuorescence intensity in isotonic buﬀer just before and 140s after switching from isotonic to
hypotonic condition. N = 14 (control) and 16 (CDX-treated) myoﬁbers from ﬁve diﬀerent isolations. ∗∗∗P<0.001.
was below the resolution limit (<200nm) of the confocal
microscope. The dots located to the borderlines of the sar-
colemmal domains, but during overexpression conditions,
there were low-intensity dots also within the DGC domains.
Compatiblewiththis,apreviousstudyshowedthatinﬂuenza
virions were budding at the DGC domains during inﬂuenza
virus infection that typically results in overexpression [4]. It
is notable that removal of all known raft-targeting signals
from HA did not change its distribution pattern. Impor-
tantly, the dot-like appearance of HA did not change, either.
It thus seems that HA molecules form small aggregates both
in raft and nonraft environments, and these locate to the
DGCborderlines, andtheir size isnot dependent on thelipid
environment. This idea is compatible with ﬁndings of the
recent study in which the clustering of the transmembrane
domains of HA was found to take place independently of
raft association [39]. Regarding the localization, it is possible
that anchoring to the subsarcolemmal cytoskeleton plays a
role. It is notable that the native transmembrane proteins
aquaporin 4 and Na,K-ATPase are associated with the DGCBiochemistry Research International 9
(a) (b) (c)
(d) (e)
(f) (g)
Figure 6: HA localizes to the DGC-deﬁcient domains independently of raft association. Double immunoﬂuorescence staining for the
sarcolemmal wild-type HA (green) and β-dystroglycan (red) is shown at the sarcolemma level (a) and at the middle of the ﬁber (b). Double
immunoﬂuorescence staining for a noninfected control shows no HA (c). At high expression level, HA occupies regions of β-dystroglycan
(DGC-rich domain) (d). Treatment with 5mM CDX does not change the distribution pattern of wild-type HA and β-dystroglycan (e). The
distribution pattern of the nonraft-associated mutant HA lacking the palmitoylation sites and transmembrane raft-targeting signals also
remained unchanged as shown by double staining for β-dystroglycan (f). Primary antibody incubation was performed at 10–12◦Cf o r1 . 5h
before the ﬁxation with 3% paraformaldehyde (a–f). Fixation of the myoﬁber before application of the anti-HA antibodies did not change
the distribution pattern (g). The pictures have undergone brightness and contrast adjustment. Scale bar, 2μm.
domains via binding to subsarcolemmal α-syntrophin and
ankyrin-3, respectively [6, 40, 41]. Taken together, we have
shown that raft proteins are not evenly distributed in the
sarcolemmabutlocateindiscreteregionswithinthedomains
deﬁned by DGC. However, the role of the lipid platform
in dictating the domain-speciﬁc distribution of the proteins
varied. It remains to be determined whether the binding of
the cytoplasmic tails to the subsarcolemmal cytoskeleton was
responsible for the domain-speciﬁc partitioning.
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